Epix up on GSK deal

EPIX gained $1.67 (30%) to $7.19 on 6.8 million shares on Tuesday after the company partnered

Read the full 160 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE